Shimadzu and UMG Göttingen Enter Analytics Collaboration
The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.
Considerations for a Successful Reformulation Strategy
Companies need to consider and address formulation challenges to employ a successful reformulation strategy.
Taking a Closer Look at Lipid Nanoparticle Characterization
An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
Gerresheimer and Nelson Labs NV Announce E&L Partnership
Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.
Lonza and Singzyme Enter Bioconjugates Partnership
Lonza and Singzyme will use Singzyme’s enzymatic conjugation platform to develop novel bioconjugates.
CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies
The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.
Gilead and MacroGenics Enter $1.7 Billion Oncology Collaboration
Gilead and MacroGenics will work together on bispecific antibodies for the treatment of blood cancers.
Merck and Moderna Enter $250 Million Cancer Vaccine Partnership
Merck has exercised a $250 million option with Moderna to jointly develop and commercialize cancer vaccine mRNA-4157/V940.
Alexion, AstraZeneca Acquire Genomic Medicines Company
Alexion’s acquisition of LogicBio is designed to accelerate the company’s growth in genomic medicines.
FDA Expands Oversight of Cell and Gene Therapies
CBER maps modernization plan to handle surge in research and applications.